Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins
TianMeng XuiD, Rachel Heon‐RobertsiD, Travis Moore, Patricia DubotiD, Xuefang PaniD, Tianlin GuoiD, Christopher W. CairoiD, Rebecca J. HolleyiD, Brian BiggeriD, Thomas M. DurcaniD, Thierry LevadeiD, Jérôme AusseiliD, Bénédicte AmilhoniD, Alexei GorelikiD, Bhushan NagariD, Shaukat Ali KhaniD, Shunji TomatsuiD, Luisa SturialeiD, Angelo PalmigianoiD, Iris RöckleiD, Hauke ThiesleriD, Herbert HildebrandtiD, Domenico GarozzoiD, Alexey V. PshezhetskyiD
Abstract
Mucopolysaccharidoses (MPS) are lysosomal storage diseases caused by defects in catabolism of glycosaminoglycans. MPS I, II, III and VII are associated with lysosomal accumulation of heparan sulphate and manifest with neurological deterioration. Most of these neurological MPS currently lack effective treatments. Here, we report that, compared to controls, neuraminidase 1 (NEU1) activity is drastically reduced in brain tissues of neurological MPS patients and in mouse models of MPS I, II, IIIA, IIIB and IIIC, but not of other neurological lysosomal disorders not presenting with heparan sulphate storage. We further show that accumulated heparan sulphate disrupts the lysosomal multienzyme complex of NEU1 with cathepsin A (CTSA), {beta}-galactosidase (GLB1) and glucosamine-6-sulfate sulfatase (GALNS) necessary to maintain enzyme activity, and that NEU1 deficiency is linked to partial deficiencies of GLB1 and GALNS in cortical tissues and iPSC-derived cortical neurons of neurological MPS patients. Increased sialylation of N-linked glycans in brain samples of human MPS III patients and MPS IIIC mice implicated insufficient processing of brain N-linked sialylated glycans, except for polysialic acid, which was reduced in the brains of MPS IIIC mice. Correction of NEU1 activity in MPS IIIC mice by lentiviral gene transfer ameliorated previously identified hallmarks of the disease, including memory impairment, behavioural traits, and reduced levels of the excitatory synapse markers VGLUT1 and PSD95. Overexpression of NEU1 also restored levels of VGLUT1-/PSD95-positive puncta in cortical neurons derived from iPSC of an MPS IIIA patient. Together, our data demonstrate that heparan sulphate-induced secondary NEU1 deficiency and aberrant sialylation of glycoproteins implicated in synaptogenesis, memory, and behaviour constitute a novel pathological pathway in neurological MPS spectrum crucially contributing to CNS pathology. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=89 SRC="FIGDIR/small/587986v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@3905c3org.highwire.dtl.DTLVardef@1a9672corg.highwire.dtl.DTLVardef@b4911forg.highwire.dtl.DTLVardef@a3b190_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 4.29
- Field percentile
- top 6%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Early defects in lysosomal storage diseases disrupt excitatory synaptic transmission
Camila De Britto Pará De Aragão, Luigi Bruno, … Alexey V. Pshezhetsky·bioRxiv·Jul 6, 2020
- Systems-level investigation of mucopolysaccharidosis IIIA identifies deficient synaptic activity as a key driver of disease progression
Alon M. Douek, Adrian Salavaty, … Jan Kaslin·bioRxiv·Oct 3, 2022
- Oral Glucosamine Ameliorates Aggravated Neurological Phenotype in Mucopolysaccharidosis III Type C Mouse Model Expressing Misfolded HGSNAT Variant
X. Pan, M. Taherzadeh, … A. V. Pshezhetsky·bioRxiv·Aug 26, 2021
- Severe Central Nervous System Demyelination in Sanfilippo Disease
Mahsa Taherzadeh, Erjun Zhang, … Alexey V. Pshezhetsky·Frontiers in Molecular NeurosciencePeer-reviewed·Dec 12, 2023
- Synthetic analogue of adrenocorticotropic hormone, ACTH(4-7)PGP delays neurological manifestations in diseases of mucopolysaccharidosis III spectrum by reducing neuroinflammation and rescuing neurotransmission, synaptogenesis, and axonal demyelination
Travis Mooree, Patricia Dubot, … Alexey V. Pshezhetsky·bioRxiv·Feb 24, 2026
- Heterologous HSPC transplantation rescues neuroinflammation and ameliorates peripheral manifestations in the mouse model of lysosomal transmembrane enzyme deficiency, MPS IIIC.
Xuefang Pan, Antoine Caillon, … Alexey V. Pshezhetsky·CellsPeer-reviewed·May 20, 2024